Hopkins researchers help secure full FDA approval to treat immunocompromised COVID-19 patients—paving the way to explore ...

U.S. Sen. Rand Paul, the new chairman of the Senate’s Homeland Security and Governmental Affairs Committee, said Thursday a ...

The endTB trial is one of four recent randomized controlled trials testing new, shorter, and less toxic treatment regimens ...

This article originally appeared on the Bloomberg School of Public Health website.Researchers from the Johns Hopkins ...

Tirzepatide is a long-acting agonist of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors that results in 12 to 21% weight loss in patients with obesity; however ...

The CDC has instructed its scientists to retract or pause the publication of any research manuscript being considered by any ...

For over 200 years, the New England Journal of Medicine (NEJM) has brought important medical news to the world’s most influential physicians. The global medical community, physicians ...

The study also evaluated the effectiveness of public health measures, such as travel restrictions, in reducing the spread ...

The next phase of pre-exposure prophylaxis against SARS-CoV-2 currently rests on the shoulders of a single monoclonal ...

Post-lockdown, child mortality rates in England increased, revealing significant disparities and ongoing challenges in ...

While child deaths in England fell temporarily during the COVID-19 pandemic, they have now risen to new heights, a new study from researchers at the University of Bristol and based on unique National ...

New England Business Media ... a daily update of the area’s most important business news. Worcester Business Journal provides the top coverage of news, trends, data, politics and personalities ...